169 related articles for article (PubMed ID: 17725340)
1. Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging.
Xu H; Baidoo K; Gunn AJ; Boswell CA; Milenic DE; Choyke PL; Brechbiel MW
J Med Chem; 2007 Sep; 50(19):4759-65. PubMed ID: 17725340
[TBL] [Abstract][Full Text] [Related]
2. A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiol-containing biomolecules.
Xu H; Baidoo KE; Wong KJ; Brechbiel MW
Bioorg Med Chem Lett; 2008 Apr; 18(8):2679-83. PubMed ID: 18359632
[TBL] [Abstract][Full Text] [Related]
3. Toward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging.
Xu H; Eck PK; Baidoo KE; Choyke PL; Brechbiel MW
Bioorg Med Chem; 2009 Jul; 17(14):5176-81. PubMed ID: 19505829
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation.
Ingargiola M; Dittfeld C; Runge R; Zenker M; Heldt JM; Steinbach J; Cordes N; Baumann M; Kotzerke J; Kunz-Schughart LA
Cytometry A; 2012 Oct; 81(10):865-73. PubMed ID: 22930585
[TBL] [Abstract][Full Text] [Related]
5. In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
Schneider DW; Heitner T; Alicke B; Light DR; McLean K; Satozawa N; Parry G; Yoo J; Lewis JS; Parry R
J Nucl Med; 2009 Mar; 50(3):435-43. PubMed ID: 19223400
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro evaluation of 111In-CHX-A"-DTPA-labeled anti-VEGF monoclonal antibody bevacizumab.
Hosseinimehr SJ; Orlova A; Tolmachev V
Hum Antibodies; 2010; 19(4):107-11. PubMed ID: 21178282
[TBL] [Abstract][Full Text] [Related]
7. Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.
Milenic DE; Wong KJ; Baidoo KE; Nayak TK; Regino CA; Garmestani K; Brechbiel MW
MAbs; 2010; 2(5):550-64. PubMed ID: 20716957
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent.
Ray GL; Baidoo KE; Wong KJ; Williams M; Garmestani K; Brechbiel MW; Milenic DE
Br J Pharmacol; 2009 Aug; 157(8):1541-8. PubMed ID: 19681874
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.
Nayak TK; Regino CA; Wong KJ; Milenic DE; Garmestani K; Baidoo KE; Szajek LP; Brechbiel MW
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1368-76. PubMed ID: 20155263
[TBL] [Abstract][Full Text] [Related]
10. p-NO
Spreckelmeyer S; Ramogida CF; Rousseau J; Arane K; Bratanovic I; Colpo N; Jermilova U; Dias GM; Dude I; Jaraquemada-Peláez MG; Bénard F; Schaffer P; Orvig C
Bioconjug Chem; 2017 Aug; 28(8):2145-2159. PubMed ID: 28683198
[TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.
Price EW; Edwards KJ; Carnazza KE; Carlin SD; Zeglis BM; Adam MJ; Orvig C; Lewis JS
Nucl Med Biol; 2016 Sep; 43(9):566-576. PubMed ID: 27419360
[TBL] [Abstract][Full Text] [Related]
12. PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.
Nayak TK; Garmestani K; Baidoo KE; Milenic DE; Brechbiel MW
Int J Cancer; 2011 Feb; 128(4):920-6. PubMed ID: 20473899
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides.
Garmestani K; Yao Z; Zhang M; Wong K; Park CW; Pastan I; Carrasquillo JA; Brechbiel MW
Nucl Med Biol; 2001 May; 28(4):409-18. PubMed ID: 11395314
[TBL] [Abstract][Full Text] [Related]
14. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
15. Preparation and comparative evaluation of 99mTc-labeled 2-iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies.
Mishra AK; Iznaga-Escobar N; Figueredo R; Jain VK; Dwarakanath BS; Pérez-Rodríguez R; Sharma RK; Mathew TL
Methods Find Exp Clin Pharmacol; 2002 Dec; 24(10):653-60. PubMed ID: 12616957
[TBL] [Abstract][Full Text] [Related]
16. HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts.
Nayak TK; Garmestani K; Milenic DE; Baidoo KE; Brechbiel MW
PLoS One; 2011 Mar; 6(3):e18198. PubMed ID: 21464917
[TBL] [Abstract][Full Text] [Related]
17. Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.
Clifford T; Boswell CA; Biddlecombe GB; Lewis JS; Brechbiel MW
J Med Chem; 2006 Jul; 49(14):4297-304. PubMed ID: 16821789
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and testing of a binary catalytic system for imaging of signal amplification in vivo.
Bogdanov A; Kang HW; Querol M; Pretorius PH; Yudina A
Bioconjug Chem; 2007; 18(4):1123-30. PubMed ID: 17508710
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of methods for large scale preparation of antibody ligand conjugates.
Wu C; Gansow OA; Brechbiel MW
Nucl Med Biol; 1999 Apr; 26(3):339-42. PubMed ID: 10363806
[No Abstract] [Full Text] [Related]
20. Generation of DOTA-conjugated antibody fragments for radioimmunoimaging.
Smith-Jones PM; Solit DB
Methods Enzymol; 2004; 386():262-75. PubMed ID: 15120256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
